Integrated Functional Genomic Analysis Enables Annotation of Kidney Genome-Wide Association Study Loci.

Epigenetics Human genomics gene transcription mesangial cells podocyte tubule cells

Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 23 03 2018
accepted: 26 12 2018
pubmed: 15 2 2019
medline: 15 2 2019
entrez: 15 2 2019
Statut: ppublish

Résumé

Linking genetic risk loci identified by genome-wide association studies (GWAS) to their causal genes remains a major challenge. Disease-associated genetic variants are concentrated in regions containing regulatory DNA elements, such as promoters and enhancers. Although researchers have previously published DNA maps of these regulatory regions for kidney tubule cells and glomerular endothelial cells, maps for podocytes and mesangial cells have not been available. We generated regulatory DNA maps (DNase-seq) and paired gene expression profiles (RNA-seq) from primary outgrowth cultures of human glomeruli that were composed mainly of podocytes and mesangial cells. We generated similar datasets from renal cortex cultures, to compare with those of the glomerular cultures. Because regulatory DNA elements can act on target genes across large genomic distances, we also generated a chromatin conformation map from freshly isolated human glomeruli. We identified thousands of unique regulatory DNA elements, many located close to transcription factor genes, which the glomerular and cortex samples expressed at different levels. We found that genetic variants associated with kidney diseases (GWAS) and kidney expression quantitative trait loci were enriched in regulatory DNA regions. By combining GWAS, epigenomic, and chromatin conformation data, we functionally annotated 46 kidney disease genes. We demonstrate a powerful approach to functionally connect kidney disease-/trait-associated loci to their target genes by leveraging unique regulatory DNA maps and integrated epigenomic and genetic analysis. This process can be applied to other kidney cell types and will enhance our understanding of genome regulation and its effects on gene expression in kidney disease.

Sections du résumé

BACKGROUND BACKGROUND
Linking genetic risk loci identified by genome-wide association studies (GWAS) to their causal genes remains a major challenge. Disease-associated genetic variants are concentrated in regions containing regulatory DNA elements, such as promoters and enhancers. Although researchers have previously published DNA maps of these regulatory regions for kidney tubule cells and glomerular endothelial cells, maps for podocytes and mesangial cells have not been available.
METHODS METHODS
We generated regulatory DNA maps (DNase-seq) and paired gene expression profiles (RNA-seq) from primary outgrowth cultures of human glomeruli that were composed mainly of podocytes and mesangial cells. We generated similar datasets from renal cortex cultures, to compare with those of the glomerular cultures. Because regulatory DNA elements can act on target genes across large genomic distances, we also generated a chromatin conformation map from freshly isolated human glomeruli.
RESULTS RESULTS
We identified thousands of unique regulatory DNA elements, many located close to transcription factor genes, which the glomerular and cortex samples expressed at different levels. We found that genetic variants associated with kidney diseases (GWAS) and kidney expression quantitative trait loci were enriched in regulatory DNA regions. By combining GWAS, epigenomic, and chromatin conformation data, we functionally annotated 46 kidney disease genes.
CONCLUSIONS CONCLUSIONS
We demonstrate a powerful approach to functionally connect kidney disease-/trait-associated loci to their target genes by leveraging unique regulatory DNA maps and integrated epigenomic and genetic analysis. This process can be applied to other kidney cell types and will enhance our understanding of genome regulation and its effects on gene expression in kidney disease.

Identifiants

pubmed: 30760496
pii: ASN.2018030309
doi: 10.1681/ASN.2018030309
pmc: PMC6405142
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-441

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK081943
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL105756
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 by the American Society of Nephrology.

Auteurs

Karsten B Sieber (KB)

GlaxoSmithKline, LLC, Collegeville, Pennsylvania.

Anna Batorsky (A)

Altius Institute for Biomedical Sciences, Seattle, Washington.

Kyle Siebenthall (K)

Altius Institute for Biomedical Sciences, Seattle, Washington.

Kelly L Hudkins (KL)

Department of Anatomic Pathology.

Jeff D Vierstra (JD)

Altius Institute for Biomedical Sciences, Seattle, Washington.

Shawn Sullivan (S)

Phase Genomics Inc., Seattle, Washington.

Aakash Sur (A)

Phase Genomics Inc., Seattle, Washington.
Department of Biomedical and Health Informatics, and.

Michelle McNulty (M)

Division of Pediatric Nephrology, Department of Pediatrics, University of Michigan School of Medicine, Ann Arbor, Michigan; and.

Richard Sandstrom (R)

Altius Institute for Biomedical Sciences, Seattle, Washington.

Alex Reynolds (A)

Altius Institute for Biomedical Sciences, Seattle, Washington.

Daniel Bates (D)

Altius Institute for Biomedical Sciences, Seattle, Washington.

Morgan Diegel (M)

Altius Institute for Biomedical Sciences, Seattle, Washington.

Douglass Dunn (D)

Altius Institute for Biomedical Sciences, Seattle, Washington.

Jemma Nelson (J)

Altius Institute for Biomedical Sciences, Seattle, Washington.

Michael Buckley (M)

Altius Institute for Biomedical Sciences, Seattle, Washington.

Rajinder Kaul (R)

Altius Institute for Biomedical Sciences, Seattle, Washington.

Matthew G Sampson (MG)

Division of Pediatric Nephrology, Department of Pediatrics, University of Michigan School of Medicine, Ann Arbor, Michigan; and.

Jonathan Himmelfarb (J)

Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington.
Kidney Research Institute, Seattle, Washington.

Charles E Alpers (CE)

Department of Anatomic Pathology.
Kidney Research Institute, Seattle, Washington.

Dawn Waterworth (D)

GlaxoSmithKline, LLC, Collegeville, Pennsylvania.

Shreeram Akilesh (S)

Department of Anatomic Pathology, shreeram@uw.edu.
Kidney Research Institute, Seattle, Washington.

Classifications MeSH